China Nootropic Glyx 13 Powder CAS 117928-94-6, Find details about China Glyx 13 Powder, 117928-94-6 from Nootropic Glyx 13 Powder CAS 117928-94-6
Rapastinel, also known as GLYX-13 and BV-102, is a novel antidepressant drug approved as an adjunctive therapy for the treatment of treatment-resistant major depressive disorder. It is a centrally active, intravenously administered (non-orally active) amidated tetrapeptide (Thr-Pro-Pro-Thr-NH2) that acts as a selective, weak partial agonist (mixed antagonist/agonist) of an allosteric site at the glycine site of the NMDA receptor complex (Emax ≈ 25%).[1][2] The drug is a rapid-acting and long-lasting antidepressant as well as robust cognitive enhancer by virtue of its ability to both inhibit and enhance NMDA receptor-mediated signal transduction.
We are also provide :
Vinpocetine | 42971-09-5 |
Vincamine | 1617-90-9 |
phenibut | 1078-21-3 |
cdp-colina | 987-78-0 |
Citicoline sodium | 33818-15-4 |
Melanotan2 | |
Tianeptine Sulfate | 1224690-84-9 |
Tianeptine sodium | 30123-17-2 |
Tianeptine acid | 66981-73-5 |
magnesium L-Theorate | 778571-57-6 |
Sulbutiamine | 3286-46-2 |
NSI-189 Freebase and phosphate | 1270138-40-3 |
phenylpiracetam | 77472-70-9 |
Noopept | 157115-85-0 |
Alpha-GPC | 28319-77-9 |
Coluracetam | 135463-81-9 |
Oxiracetam | 62613-82-5 |
Piracetam | 7491-74-9 |
NSI-189 | 1270138-40-3 |
Sunifiram | 314728-85-3 |
Fasoracetam | 110958-19-5 |
Citicoline sodium | 33818-15-4 |
Pramiracetam | 68497-62-1 |